StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Lexicon Pharma (LXRX) to Resume Trading at 7:45 a.m.
July 30, 2020 7:42 AM
Lexicon Pharma ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
Lexicon Pharma (LXRX) Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program
July 30, 2020 7:42 AM
Lexicon Pharma (LXRX) Misses Q2 EPS by 4c, Revenues Beat
July 30, 2020 7:28 AM
Form 8-K LEXICON PHARMACEUTICALS, For: Jul 29
July 30, 2020 7:18 AM
Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program
July 30, 2020 7:15 AM
Lexicon Pharma (LXRX) Announces Sale of XERMELO for $159 Million
July 30, 2020 7:11 AM
Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO
July 30, 2020 7:10 AM
